BC patients group (n = 40) | |
---|---|
Age (years) | |
Mean ± SD | 42.52 ± 11.58 years |
Range | (31–72) years |
Histological grade | |
I | 3 (7.5%) |
II | 31 (77.5%) |
III | 6 (15%) |
Axillary lymph node involvement | |
Positive | 19 (47.5%) |
Negative | 21 (52.5%) |
ER statusa | |
Positive | 34 (95%) |
Negative | 6 (5%) |
PR statusb | |
Positive | 37 (92.5%) |
Negative | 3 (7.5%) |
Her-2/neu expressionc | |
Positive | 0 (0%) |
Negative | 40 (100%) |
Tumor type | |
IDCd | 35 (87.5%) |
Other (ILCe and MCf and NSTg) | 5 (12.5%) |
Type of surgery | |
Breast conservation | 13 (32.5%) |
Mastectomy | 27 (67.5%) |